ASTYM Therapy

Tendinopathy and scar tissue outcomes modest; not clearly superior to other soft tissue techniques.

Applicable to soft tissue and musculoskeletal caseloads; useful in outpatient ortho and sports settings.

Billed under manual therapy CPT codes; standard commercial and Medicare coverage at manual therapy rates.

2-day training course; moderate cost; requires ASTYM tool purchase; moderately accessible.

Moderate employer demand as IASTM approach; valued in orthopedic PT practices using soft tissue techniques.

Some patients respond well; discomfort during treatment is a barrier.

Some cash-pay opportunity for tendinopathy/soft-tissue niches but largely insurance-billed.

Brand exists but competes with IASTM/Graston and is not strongly premium.

Crowded soft-tissue tool space; modest differentiation only.

Protocolized and trainable across staff with licensing fees.

Limited consumer recognition; clinicians know it more than patients.

Course + per-clinician licensing fees add up; moderate ROI.

Commercial brand cert with negligible academic credibility.

Small handful of company-affiliated studies; limited independent literature.

Rarely part of core curriculum; may appear in modalities electives.

Evidence base is thin and largely industry-funded.

Not listed in faculty postings.

Time and licensing costs are not academically rewarded.